Immunovia AB (publ) ( IMMNOV.ST) - Key Metrics
IMMNOV.ST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | SEK0 | -SEK0.03 | -SEK0.04 | -SEK0.04 |
| 2025Q3 | SEK0 | -SEK0.08 | -SEK0.04 | -SEK0.06 |
| 2025Q2 | SEK0 | -SEK0.14 | -SEK0.06 | -SEK0.06 |
| 2025Q1 | SEK0 | -SEK0.24 | -SEK0.10 | -SEK0.10 |
IMMNOV.ST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.73 |
| 2025Q3 | ? | -1.25 |
| 2025Q2 | ? | -0.58 |
| 2025Q1 | ? | -0.22 |
IMMNOV.ST
Price: SEK0.20
52 week price:
Earnings Per Share: -0.26 SEK
Exchange: STO
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 127.3 million